Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Potential biomarkers and drug evaluation system for Alzheimer’s disease

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: ZHANG, Xiang (Institute of Materia Medica, Chinese Academy of Medical Sciences, Department of Pharmacology, Beijing, China)
  • Co-author(s): Xiang Zhang: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Wenwen Yu: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Yingni Sun: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Xiaoliang Wang: Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  • Abstract:

    Backgrounds

    Alzheimer’s disease (AD) is a common neurodegenerative disease among elderly people. As the pathogenesis is still unclear, the diagnosis of AD at early stage and evaluation of therapeutic effects are difficult. Recently we have demonstrated some specific expressed serum proteins in AD patients.

    Aims

    To verify the proteins changing in

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses